TeleRescue

Company Overview

Snapshot

Founded in January 2011 by Dr. Israel Shamir Lebovitz, TeleRescue operated with 1–10 employees, developing a home-based solution for sudden cardiac arrest. The company ceased operations in June 2019.

Business overview

TeleRescue specializes in Health Tech & Life Sciences, developing an autonomous defibrillation system designed to sense sudden cardiac arrest and apply defibrillation without caregiver presence. The system integrates an ECG-sensing module that continuously transmits data to a lightweight defibrillator module, serving the healthcare industry by providing remote monitoring and critical care for patients at home. The company operates within the Medical Devices and Digital Healthcare sectors, specifically focusing on Medical Monitors and Patient Remote Monitoring.

Company Intelligence Q&A

What is TeleRescue's primary focus?

TeleRescue is focused on developing an autonomous defibrillation system for home-based management of sudden cardiac arrest, aiming to provide critical care without the immediate presence of a caregiver.

When was TeleRescue founded and by whom?

TeleRescue was founded in January 2011 by Dr. Israel Shamir Lebovitz.

What is the core technology behind TeleRescue's product?

The core technology involves an ECG-sensing module that continuously transmits data wirelessly to a defibrillator module, which evaluates the data and can apply defibrillation directly or send data to a medical call center for remote command.

What is the operational status of TeleRescue?

TeleRescue is currently non-active, having ceased operations in June 2019.

What markets does TeleRescue aim to serve?

TeleRescue aims to serve the healthcare market, specifically focusing on patients requiring remote monitoring and critical care for cardiac conditions within their homes.